COVID-19

Outside of the loss of human life due to the COVID-19 pandemic, the past two years have greatly affected hospitals, health systems and the way providers deliver care. Healthcare executives are grappling with federal monetary assistance, growing burnout rates, workforce shortages and federal oversight of vaccines and testing. This channel is also designed to update clinicians on new research and guidelines regarding COVID patient treatment strategies and risk assessments.

Enhanced external counterpulsation may help patients fight against long COVID

The small study included patients with and without coronary artery disease. 

Long-term risk of heart attack, coronary artery disease or stroke much higher among COVID-19 patients

Even patients who were never hospitalized for COVID-19 face a heightened risk of cardiovascular issues.

Doctor patient with masks

New scoring system predicts stroke risk after COVID-19

The study's authors said some of their findings surprised them. 

Thumbnail

Risk of COVID-related stroke highest soon after diagnosis

“These findings can inform diagnosis, treatment and care of stroke among patients with COVID-19,” one researcher said. 

COVID-19 coronavirus burnout depression pandemic

41% of Americans have experienced heart-related issues during the pandemic

Shortness of breath, dizziness, increased blood pressure and chest pain were among the most commonly reported issues.

Thumbnail

Plant-based diets boost cardiovascular health, lower risk of severe COVID-19

Two members of the Physicians Committee for Responsible Medicine described plant-based diets as "a booster that is needed at this unprecedented time." 

RV dysfunction seen in 22% of critically ill COVID-19 patients

RV dysfunction was not associated with an elevated risk of in-hospital mortality. 

4 key takeaways from an updated look at vaccine-related myocarditis in the US

How common is vaccine-related myocarditis? How does it compare to a typical case of myocarditis? Researchers aimed to answer those questions and more. 

Around the web

GE HealthCare said the price of iodine contrast increased by more than 200% between 2017 to 2023. Will new Chinese tariffs drive costs even higher?

Several key trends were evident at the Radiological Society of North America 2024 meeting, including new CT and MR technology and evolving adoption of artificial intelligence.